Skip to main content

TARGET Data Matrix

Last Updated:

The Genomic Data Commons (GDC) is currently working on developing their whole genome sequencing (WGS) analysis pipeline. While some TARGET analyzed WGS data is already available via the GDC Data Portal, not all aliquots have completed the analysis phase. The TARGET aliquots that are currently still undergoing WGS analysis at the GDC are listed here: https://ocg.cancer.gov/TARGET-WGS-Aliquots-Undergoing-Analysis-At-GDC.

Disease Patient Data Gene Expression Copy Number Methylation miRNA Sequence Other
Acute Lymphoblastic Leukemia (ALL)
ALL Phase 1 (B-ALL)
Whole Genome
Whole Genome Lite
mRNA-seq
ALL Phase 2 (B-ALL, T-ALL, Dicentric, Xenograft)
Whole Genome
Whole Exome
mRNA-seq
ALL Phase 3 (ALAL)
Whole Genome
mRNA-seq
Acute Myeloid Leukemia (AML)
AML
Whole Genome
Whole Exome
mRNA-seq
Targeted Resequencing
Kidney Tumors
Wilms Tumor (WT)
Whole Genome
Whole Exome
mRNA-seq
Targeted Resequencing
Clear Cell Sarcoma of the Kidney (CCSK)
Whole Genome
mRNA-seq
Rhabdoid Tumor (RT)
Whole Genome
mRNA-seq
Bisulfite-seq
Neuroblastoma (NBL)
NBL
Whole Genome
Whole Exome
mRNA-seq
Targeted Resequencing
Osteosarcoma (OS)
OS
Whole Genome
Whole Exome
mRNA-seq
Pan-cancer Model Systems (MDLS)
NBL Model Systems
Whole Genome
Whole Exome
Pediatric Preclinical Testing Program (PPTP)
Whole Exome
TARGET Data Legend
Blue: Public*
Red: Protected†
Black: Unavailable

All DCC Controlled† access links require an eRA Commons account via Globus.org
All FASTQ/BAM† are controlled access links and require an eRA Commons account